<p>阿爾凱默斯（NASDAQ: ALKS）正在準備於 2026 年 2 月 25 日公佈其季度財報。以下是投資者在發佈前應瞭解的簡要概述。</p>
<p>分析師預計阿爾凱默斯將報告每股收益（EPS）為 0.38 美元。</p>
<p>阿爾凱默斯的公告備受期待，投資者希望看到超出預期的消息以及對下個季度的積極指引。</p>
<p>值得新投資者注意的是，指引可能是股價波動的關鍵因素。</p>
<h3>之前財報的表現</h3>
<p>上個季度，該公司每股收益超出預期 0.12 美元，隨後股價在第二天上漲了 1.45%。</p>
<p>以下是阿爾凱默斯過去表現及其價格變化的概覽：</p>
<table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 預估</strong></td>
<td align="right">0.37</td>
<td align="right">0.34</td>
<td align="right">0.24</td>
<td align="right">0.76</td>
</tr>
<tr>
<td><strong>EPS 實際</strong></td>
<td align="right">0.49</td>
<td align="right">0.52</td>
<td align="right">0.13</td>
<td align="right">1.04</td>
</tr>
<tr>
<td><strong>價格變化 %</strong></td>
<td align="right">1.00</td>
<td align="right">3.00</td>
<td align="right">4.00</td>
<td align="right">7.00</td>
</tr>
</tbody>
</table>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771952541_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="eps graph" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771952541_0.png"/></p>
<h3>阿爾凱默斯股票表現</h3>
<p>截至 2 月 23 日，阿爾凱默斯的股票交易價格為 32.19 美元。在過去 52 周內，股票下跌了 3.88%。鑑於這些回報通常是負面的，長期股東在此次財報發佈前可能持悲觀態度。</p>
<h3>分析師對阿爾凱默斯的看法</h3>
<p>對於投資者而言，瞭解市場情緒和行業預期至關重要。本分析提供了關於阿爾凱默斯的最新見解。</p>
<p>根據分析師評級，阿爾凱默斯的共識評級為，平均一年價格目標為$，存在潛在。</p>
<p>要跟蹤阿爾凱默斯的所有財報發佈，請訪問我們網站上的財報日曆。</p>
<p><em>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</em></p>

醫藥突破 ETF - ALPS

紐交所高增長板生物技術指數 ETF - First Trust

醫療業 ETF - SPDR

<p>阿爾凱默斯 (NASDAQ:ALKS) 定於 2026 年 2 月 25 日公佈季度財報，分析師預計每股收益 (EPS) 為 0.38 美元。該公司之前超出每股收益預期 0.12 美元，導致股價上漲 1.45%。目前，股票交易價格為 32.19 美元，過去一年下跌 3.88%，顯示出長期股東的悲觀情緒。分析師強調了指引在股價波動中的重要性，市場共識評級在財報發佈前反映出謹慎的樂觀情緒</p>

<p>Alkermes (NASDAQ: ALKS) is gearing up to announce its quarterly earnings on Wednesday, 2026-02-25. Here's a quick overview of what investors should know before the release.</p>
<div class="lb-trans"><p>阿爾凱默斯（NASDAQ: ALKS）正在準備於 2026 年 2 月 25 日公佈其季度財報。以下是投資者在發佈前應瞭解的簡要概述。</p>
</div><p>Analysts are estimating that Alkermes will report an <strong>earnings per share</strong> (EPS) of $0.38.</p>
<div class="lb-trans"><p>分析師預計阿爾凱默斯將報告每股收益（EPS）為 0.38 美元。</p>
</div><p>The announcement from Alkermes is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<div class="lb-trans"><p>阿爾凱默斯的公告備受期待，投資者希望看到超出預期的消息以及對下個季度的積極指引。</p>
</div><p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<div class="lb-trans"><p>值得新投資者注意的是，指引可能是股價波動的關鍵因素。</p>
</div><h3>Performance in Previous Earnings</h3>
<div class="lb-trans"><h3>之前財報的表現</h3>
</div><p>Last quarter the company beat EPS by $0.12, which was followed by a 1.45% increase in the share price the next day.</p>
<div class="lb-trans"><p>上個季度，該公司每股收益超出預期 0.12 美元，隨後股價在第二天上漲了 1.45%。</p>
</div><p>Here's a look at Alkermes's past performance and the resulting price change:</p>
<div class="lb-trans"><p>以下是阿爾凱默斯過去表現及其價格變化的概覽：</p>
</div><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th align="right"><strong>Q3 2025</strong></th>
<th align="right"><strong>Q2 2025</strong></th>
<th align="right"><strong>Q1 2025</strong></th>
<th align="right"><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td align="right">0.37</td>
<td align="right">0.34</td>
<td align="right">0.24</td>
<td align="right">0.76</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td align="right">0.49</td>
<td align="right">0.52</td>
<td align="right">0.13</td>
<td align="right">1.04</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td align="right">1.00</td>
<td align="right">3.00</td>
<td align="right">4.00</td>
<td align="right">7.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 預估</strong></td>
<td align="right">0.37</td>
<td align="right">0.34</td>
<td align="right">0.24</td>
<td align="right">0.76</td>
</tr>
<tr>
<td><strong>EPS 實際</strong></td>
<td align="right">0.49</td>
<td align="right">0.52</td>
<td align="right">0.13</td>
<td align="right">1.04</td>
</tr>
<tr>
<td><strong>價格變化 %</strong></td>
<td align="right">1.00</td>
<td align="right">3.00</td>
<td align="right">4.00</td>
<td align="right">7.00</td>
</tr>
</tbody>
</table>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771952541_0.png" alt="eps graph" original-src="https://www.benzinga.com/files/images/story/2026/1771952541_0.png"/></p>
<h3>Performance of Alkermes Shares</h3>
<div class="lb-trans"><h3>阿爾凱默斯股票表現</h3>
</div><p>Shares of Alkermes were trading at $32.19 as of February 23. Over the last 52-week period, shares are down 3.88%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.</p>
<div class="lb-trans"><p>截至 2 月 23 日，阿爾凱默斯的股票交易價格為 32.19 美元。在過去 52 周內，股票下跌了 3.88%。鑑於這些回報通常是負面的，長期股東在此次財報發佈前可能持悲觀態度。</p>
</div><h3>Analysts' Take on Alkermes</h3>
<div class="lb-trans"><h3>分析師對阿爾凱默斯的看法</h3>
</div><p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Alkermes.</p>
<div class="lb-trans"><p>對於投資者而言，瞭解市場情緒和行業預期至關重要。本分析提供了關於阿爾凱默斯的最新見解。</p>
</div><p>The consensus rating for Alkermes is , based on analyst ratings. With an average one-year price target of $, there's a potential .</p>
<div class="lb-trans"><p>根據分析師評級，阿爾凱默斯的共識評級為，平均一年價格目標為$，存在潛在。</p>
</div><p>To track all earnings releases for Alkermes visit their earnings calendar on our site.</p>
<div class="lb-trans"><p>要跟蹤阿爾凱默斯的所有財報發佈，請訪問我們網站上的財報日曆。</p>
</div><p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>
<div class="lb-trans"><p><em>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</em></p>
</div>

阿爾凱默斯即將發佈的財報洞察